BlackRock Fund Advisors’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
BIT
BlackRock Fund Advisors's HAE Position: Q4 2016 in Review
BlackRock Fund Advisors increased its Haemonetics (HAE) stake by 14% in Q4 2016, buying an estimated $19.6M and bringing the position to 4,137,423 shares worth $166M. The position accounts for 0.03% of the portfolio, ranked #796.
BlackRock Fund Advisors first reported a position in HAE in Q2 2013 and has held it in 15 quarters since. 198 funds tracked by Wall St. Rank hold HAE as of Q4 2016.
- BlackRock Fund Advisors held 4,137,423 shares of Haemonetics worth $166M as of Q4 2016.
- BlackRock Fund Advisors bought 520,761 Haemonetics shares in Q4 2016, an estimated $19.6M.
- Haemonetics made up 0.03% of BlackRock Fund Advisors's portfolio in Q4 2016, its #796 holding.
- BlackRock Fund Advisors first reported a position in Haemonetics in Q2 2013 and has held it in 15 quarters since.
- 198 funds tracked by Wall St. Rank held Haemonetics as of Q4 2016.
Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.